Conference Reports for NATAP
HIVR4P 2024
5th HIV Research for
Prevention Conference
Lima, Peru - Oct 6-10 2024
Back
 
Tweet
Global racial, ethnic, and gender diversity among participants enrolled in the PURPOSE-2 trial of lenacapavir for pre-exposure prophylaxis (PrEP)
Jorge Gallardo-Cartagena